Bristol-Myers Squibb Co. (NYSE:BMY) Q1 2018 Earnings Call April 26, 2018 10:30 AM ET
Executives
John E. Elicker - Bristol-Myers Squibb Co.
Giovanni Caforio - Bristol-Myers Squibb Co.
Charles A. Bancroft - Bristol-Myers Squibb Co.
Murdo Gordon - Bristol-Myers Squibb Co.
Thomas J. Lynch, Jr., M.D. - Bristol-Myers Squibb Co.
Analysts
Jason M. Gerberry - Bank of America Merrill Lynch
Christopher Schott - JPMorgan Securities LLC
Jami Rubin - Goldman Sachs & Co. LLC
Umer Raffat - Evercore ISI
Andrew S. Baum - Citigroup Global Markets Ltd.
John T. Boris - SunTrust Robinson Humphrey, Inc.
Geoffrey Meacham - Barclays Capital, Inc.
Timothy Minton Anderson - Sanford C. Bernstein & Co. LLC
Matthew Phipps - William Blair & Co. LLC
Gregg Gilbert - Deutsche Bank Securities, Inc.
Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC
David R. Risinger - Morgan Stanley & Co. LLC
Steve Scala - Cowen & Co. LLC
Operator
Good day, and welcome to the Bristol-Myers Squibb 2018 First Quarter Results Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.
